| The Effectiveness of Assertive Community Treatment on Schizophrenic Patients (NCT04511663) | Shanghai Mental Health Center | 2017-07-01 |
| Trial to Evaluate the Short-term Safety & Efficacy of Brexpiprazole Monotherapy in the Treatment of Adolescents With Schizophrenia (NCT03198078) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-06-30 |
| Aripiprazole IM Depot for Chinese Patients With Schizophrenia (NCT03287505) | Otsuka Beijing Research Institute | 2017-06-23 |
| Evaluation of Metamemory Using a Semantic Construction Strategy in Patients With Schizophrenia (NCT02932059) | University Hospital, Clermont-Ferrand | 2017-06-19 |
| Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 (NCT03201757) | Alkermes, Inc. | 2017-06-15 |
| Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia (NCT03150771) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-06-14 |
| Study to Evaluate the Efficacy of ALKS 3831 on Body Weight in Young Adults Who Have Been Recently Diagnosed With Schizophrenia, Schizophreniform, or Bipolar I Disorder (NCT03187769) | Alkermes, Inc. | 2017-06-08 |
| Virtual Reality Job Interview Training in Severe Mental Illness (NCT03049813) | University of Michigan | 2017-06-01 |
| Naltrexone-Bupropion Versus Placebo-Bupropion for Weight Loss in Schizophrenia (NCT03132571) | Yale University | 2017-06-01 |
| Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cannabis Use and Cognitive Outcomes in Schizophrenia (NCT03189810) | Centre for Addiction and Mental Health | 2017-06-01 |
| Effect of Intermittent Theta Burst Stimulation (iTBS) for Alleviating Symptoms of Schizophrenia Patients (NCT03868358) | WANG KAI | 2017-05-21 |
| Minnesota Community-Based Cognitive Training in Early Psychosis (NCT03079024) | University of Minnesota | 2017-05-19 |
| Goal Management Training for Patients With Schizophrenia or High Risk for Schizophrenia (NCT03048695) | Sykehuset Innlandet HF | 2017-05-18 |
| Ginkgo Biloba Extract in the Treatment of Schizophrenia (NCT05258123) | Beijing HuiLongGuan Hospital | 2017-05-15 |
| The Effects of Prebiotics on Cognitive Functioning and Weight Gain in Psychosis (NCT03153046) | University of Oxford | 2017-05-08 |
| Study of add-on Ramelteon Therapy on Sleep and Circadian Rhythm Disruption in Patients With Schizophrenia (NCT03075657) | All India Institute of Medical Sciences, Bhubaneswar | 2017-05-01 |
| Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care. (NCT03240380) | Universitätsklinikum Hamburg-Eppendorf | 2017-05-01 |
| Explorations of the Normal Neural Behavioral and Pathological Bases of Metacognition (NCT03140475) | Versailles Hospital | 2017-04-27 |
| Role of Antioxidants (Vitamin C and E) in the Management of Schizophrenia (NCT04078048) | University of Health Sciences Lahore | 2017-04-27 |
| Safety, Tolerability and Pharmacokinetics of AUT00206 in Patients With Schizophrenia, and Also Explores the Effects of AUT00206 on Relevant Central Biomarkers. (NCT03164876) | Autifony Therapeutics Limited | 2017-04-20 |
| Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia. (NCT02512367) | Centre Hospitalier Universitaire Dijon | 2017-04-20 |
| Future Mental Projections in Schizophrenia (NCT03040505) | University Hospital, Strasbourg, France | 2017-04-05 |
| The Effect of a Community-based LAI-treated Management Model on the Violence Risk of Patients With Schizophrenia (NCT03080194) | Maosheng Fang | 2017-04-01 |
| HDAC Inhibitor Augmentation to Clozapine (NCT03263533) | Virginia Commonwealth University | 2017-04-01 |
| Inflammatory Response In Schizophrenia (NCT03093064) | King's College London | 2017-04-01 |
| The Outcomes Among Persons With Schizophrenia Under the Peer-support Service in Vocational Rehabilitation Program (NCT04767204) | Yu-Li Hospital | 2017-04-01 |
| "Art Therapy" in Acute Psychiatry (NCT03575442) | Unidade Local de Saúde de Coimbra, EPE | 2017-04-01 |
| The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia (NCT03077347) | University of California, Davis | 2017-04-01 |
| Minocycline and Tobacco Craving in Smokers With Schizophrenia (NCT02968602) | University of Maryland, Baltimore | 2017-03-31 |
| Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults (NCT02261519) | SyneuRx International (Taiwan) Corp | 2017-03-29 |
| Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia (NCT02420015) | Duke University | 2017-03-27 |
| Procedures for Sample Acquisition and Distribution for The Human Brain Collection Core (NCT03092687) | National Institute of Mental Health (NIMH) | 2017-03-21 |
| Time,Self and Spontaneous Mental Activities in Patients With Psychotic Disorders (NCT02765880) | University Hospital, Strasbourg, France | 2017-03-16 |
| Music to Reduce Use of Smoking in Patients With Schizophrenia (NCT03190161) | NYU Langone Health | 2017-03-09 |
| Study of m-RESIST, an m-Health Program for Treatment-resistant Schizophrenia (NCT03064776) | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 2017-03-01 |
| Multimodal Physical Therapy Program in Schizophrenia (NCT02413164) | University of Malaga | 2017-03-01 |
| The Appeal and Impact of E-cigarettes in Smokers With SMI (NCT03050853) | Dartmouth-Hitchcock Medical Center | 2017-03-01 |
| Magnetic Seizure Therapy for Schizophrenia (NCT02746965) | Shanghai Mental Health Center | 2017-03-01 |
| Evaluation of a Visual Remediation Intervention for Schizophrenia (NCT03117452) | Rutgers, The State University of New Jersey | 2017-02-23 |
| Cognitive Behavioral Social Skills Training in Early Onset Psychosis (NCT03261557) | Hospital Clinic of Barcelona | 2017-02-22 |
| Sulforaphane to Reduce Symptoms of Schizophrenia (NCT02810964) | Sheppard Pratt Health System | 2017-02-22 |
| INCLUDE: Using Lived Experience to Improve Mental Health Diagnosis v1 (NCT03131505) | Norfolk and Suffolk NHS Foundation Trust | 2017-02-22 |
| Emotional Response in Psychiatric and Control Participants (NCT03056781) | University of California, Irvine | 2017-02-15 |
| Emotion and Motivation in Patients With Psychosis (NCT02853019) | University Hospital, Strasbourg, France | 2017-02-02 |
| An Extension Study of Safety and Tolerability of SEP-363856 in Adult Subjects With Schizophrenia (NCT02970929) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-01-31 |
| Sustainable Early Episode Clinic Study (SEEC) (NCT03571685) | Janssen Scientific Affairs, LLC | 2017-01-31 |
| Comparing Thinking Skills for Work (TSW)Home Practice Program With Traditional TSW Program (NCT03005574) | Boston University Charles River Campus | 2017-01-27 |
| Effects of Aripiprazole (LAI) on Phychosocial/Cognitive Functioning, pt Reported AcceptabilityofTreatment in Sch (NCT02697045) | Abdi İbrahim Otsuka | 2017-01-04 |
| Cognitive Remediation Therapy in Schizophrenia: Effects on Epigenetics (NCT04278027) | Hospital Clinic of Barcelona | 2017-01-03 |
| Ketamine's Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain (NCT03915938) | Hospital de Clinicas de Porto Alegre | 2017-01-02 |
| Treatment of Auditory Hallucinations in Schizophrenia With Bilateral Theta Burst Stimulation (NCT02670291) | University Hospital Tuebingen | 2017-01-01 |
| The Motor Neurological Soft Signs (MNSS) in Persons With Schizophrenia (NCT04495998) | Faculdade de Motricidade Humana | 2017-01-01 |
| High Frequency rTMS Treatment for Cognitive Impairments in Chronic Schizophrenia Patients (NCT03774927) | Beijing HuiLongGuan Hospital | 2017-01-01 |
| Extension Study of Pimavanserin for the Adjunctive Treatment of Schizophrenia (NCT03121586) | ACADIA Pharmaceuticals Inc. | 2017-01-01 |
| Examining Persistence in Smokers With Schizophrenia (NCT03346291) | Rutgers, The State University of New Jersey | 2017-01-01 |
| A 6-month Study to Evaluate Sulforaphane add-on Effects in Treatment of Schizophrenia (NCT02880462) | Central South University | 2016-12-26 |
| Evaluation of Internet-based Cognitive Behavioral Self-help Treatments for People With Psychosis (NCT02974400) | University of Bern | 2016-12-06 |
| A Study to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Adults With Schizophrenia (NCT02969382) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2016-12-05 |
| Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in Italy (NCT03005769) | Otsuka Pharmaceutical Europe Ltd | 2016-12-01 |
| RC2S+: Remediation of Social Cognitive Impairments (NCT02976077) | Hôpital le Vinatier | 2016-11-29 |
| Study on Examination of Therapeutic Efficacy and Potential Mechanisms of Yoga Treatment in Schizophrenia (NCT03379480) | National Institute of Mental Health and Neuro Sciences, India | 2016-11-11 |
| Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia (ADVANCE) (NCT02970305) | ACADIA Pharmaceuticals Inc. | 2016-11-04 |
| A Randomised Controlled Trial of Coenzyme Q10 in Patients With Schizophrenia and Schizoaffective Disorder (NCT03576911) | University of Dublin, Trinity College | 2016-11-01 |
| Clinical Trial of AVL-3288 in Schizophrenia Patients (NCT02978599) | New York State Psychiatric Institute | 2016-11-01 |
| Study on Predictiors and Mechanism of Conversion to Psychosis in Individuals at Ultra-high Risk Group (NCT03965598) | Second Xiangya Hospital of Central South University | 2016-11-01 |
| The Optimal Treatment for Treatment-resistant Schizophrenia (NCT02926976) | Shanghai Mental Health Center | 2016-11-01 |
| PET Imaging Study of Amish and Mennonite Patients With CNTNAP2 Mutations (NCT02983058) | Jeffrey A. Lieberman, MD | 2016-11-01 |
| Efficacy and Safety of Adjunctive Pimavanserin for the Treatment of Schizophrenia (ENHANCE-1) (NCT02970292) | ACADIA Pharmaceuticals Inc. | 2016-10-26 |
| Effects of Pilates Exercise Program in Patients With Schizophrenia (NCT03714698) | Hacettepe University | 2016-10-12 |
| Basic Auditory Processing and Auditory Hallucinations (NCT02887794) | Hôpital le Vinatier | 2016-10-06 |
| Predicting Antipsychotic Discontinuation in Psychosis (NCT02884518) | Seoul National University Hospital | 2016-10-04 |
| Magnetic Seizure Therapy Versus Electroconvulsive Therapy for Schizophrenia (NCT03007628) | Shanghai Mental Health Center | 2016-10-01 |
| RCT Examining the Effectiveness of Digital Picture Frame Use in Inpatient Setting (NCT02950571) | Centre for Addiction and Mental Health | 2016-10-01 |
| Schizophrenia and the Gut Microbiome (NCT02921243) | University of Maryland, Baltimore | 2016-10-01 |
| Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia (NCT03061136) | Palo Alto Veterans Institute for Research | 2016-10-01 |
| The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation (NCT02935998) | Yang Fude | 2016-10-01 |
| Potential Intervention Strategy With Folic Acid and Vitamin B12 in Patients With Schizophrenia (NCT02916121) | Taipei Medical University WanFang Hospital | 2016-10-01 |
| Magnetic Stimulation of the Brain in Schizophrenia or Depression (NCT02905604) | Uppsala University | 2016-09-29 |
| Evaluation of Stroop Effect in Patients With Schizophrenia (NCT03163706) | University Hospital, Clermont-Ferrand | 2016-09-21 |
| Pilot Study Comparing Effects of Xanomeline Alone to Xanomeline Plus Trospium (NCT02831231) | Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2016-09-07 |
| The Impact of Caffeine on Cognition in Schizophrenia (NCT02832401) | Nova Scotia Health Authority | 2016-09-02 |
| Tocilizumab in Schizophrenia (NCT02874573) | Brian Miller | 2016-09-01 |
| MEtformin and Lorcaserin for WeighT Loss in Schizophrenia (NCT02796144) | University of North Carolina, Chapel Hill | 2016-09-01 |
| Study Investigating the Effect of Lu AF35700 on Cardiac Repolarization in Men and Women With Schizophrenia and Schizoaffective Disorder (NCT02901587) | H. Lundbeck A/S | 2016-09-01 |
| Benefits of Physical Exercise in Schizophrenia (NCT02716584) | VA Office of Research and Development | 2016-09-01 |
| The Role of Nitric Oxide in Cognition in Schizophrenia (NCT02906553) | King's College London | 2016-09-01 |
| Long-acting Paliperidone Palmitate Injection and Olanzapine for Schizophrenia (NCT02918825) | Beijing HuiLongGuan Hospital | 2016-09-01 |
| Augmentation of Neuronal Network Plasticity in Schizophrenia (NCT03522220) | Universitätsklinikum Hamburg-Eppendorf | 2016-09-01 |
| Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM) (NCT02782442) | University of Minnesota | 2016-09-01 |
| Cognitive Remediation Plus Aerobic Exercise in Schizophrenia Treatment (NCT02864576) | Parc de Salut Mar | 2016-09-01 |
| Can Cognitive Training Decrease Reactive Aggression? (NCT03623477) | Weill Medical College of Cornell University | 2016-08-16 |
| Effects of an Integrated Multimodal Lifestyle Intervention for Management of Violence in Schizophrenia (NCT05229484) | I-Shou University | 2016-08-15 |
| Mobile-Assisted Cognitive Behavior Therapy for Negative Symptoms in Schizophrenia (NCT03179696) | Eric Granholm | 2016-08-15 |
| A Phase 3, Long-term Safety and Tolerability Study of ALKS 3831 in Adults With Schizophrenia (NCT02873208) | Alkermes, Inc. | 2016-08-07 |
| Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder (NCT03043820) | Iris Sommer | 2016-08-01 |
| Switching From Twice-Daily to Once-Daily Clozapine Dosing in Schizophrenia (NCT02639702) | Centre for Addiction and Mental Health | 2016-08-01 |
| The Effects of tDCS on Illness Awareness in Schizophrenia (NCT02848885) | Centre for Addiction and Mental Health | 2016-08-01 |
| Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia (NCT02892422) | H. Lundbeck A/S | 2016-08-01 |
| Treatment of Refractory Auditory Verbal Hallucinations With tDCS in Schizophrenia (NCT02451371) | Seoul National University Hospital | 2016-08-01 |
| "Manual Dexterity and Oculomotor Control in Schizophrenia" (NCT02826629) | Centre Hospitalier St Anne | 2016-07-26 |